Usual human livers contain two major aldehyde dehydrogenase [(ALDH) aldehyde:NAD+ oxidoreductase] isozymes-i.e., a cytosolic ALDH1 component and a mitochondrial ALDH2 component-whereas o50% of Orientals are "atypical" and have only the ALDH1 isozyme and are missing the ALDH2 isozyme. We previously demonstrated that atypical livers contain an enzymatically inactive but immunologically crossreactive material (CRM) corresponding to the ALDH2 component. The enzymatically active ALDH2 obtained from a usual liver and the CRM obtained from an atypical liver were reduced, S-carboxymethylated, and digested by trypsin. Separation of their digests by high-performance reverse-phase chromatography and by two-dimensional paper chromatography and electrophoresis revealed that ALDH2 contained a peptide sequence of -Glu-Leu-Gly-Glu-Ala-GlyLeu-Gln-Ala-Asn-Val-Gln-Val-Lys-and that the glutamine adjacent to lysine was substituted by lysine in CRM. AU other tryptic peptides, including eight peptides containing S-carboxymethylcysteine, were common in ALDH2 and CRM. It is concluded that a point mutation in the human ALDH2 locus produced the glutamine -I lysine substitution and enzyme inactivation. (1, 2). The specific activity of the atypical /82P2 isozyme is nearly 100 times higher than that of the usual P1P, isozyme (2). It has been shown that the active site cysteine of the usual P, subunit is replaced by histidine in the superactive atypical P2 subunit (2).
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Racial differences in the two major liver enzymes that are involved in alcohol catabolism-i.e., alcohol dehydrogenase (alcohol:NAD+ oxidoreductase, EC 1.1.1.1) and aldehyde dehydrogenase [(ALDH) aldehyde:NAD+ oxidoreductase, EC 1.2.1.31-have been found between Caucasians and Orientals. Most Caucasians have the alcohol dehydrogenase isozymes containing the usual 831 subunit, whereas nearly 90% of Orientals have isozymes with the atypical P2 subunit (1, 2) . The specific activity of the atypical /82P2 isozyme is nearly 100 times higher than that of the usual P1P, isozyme (2) . It has been shown that the active site cysteine of the usual P, subunit is replaced by histidine in the superactive atypical P2 subunit (2) .
Virtually all Caucasians have two major ALDH isozymes-i.e., ALDH1 and ALDH2 in their livers-whereas =50% of Orientals are "atypical" in that they have only ALDH1 and are missing ALDH2 (3, 4) . A very high incidence (50-80%) of acute alcohol intoxication in Orientals could be related to the absence of active ALDH2 and the presence of superactive PA22 alcohol dehydrogenase isozyme (1, 3) . However, the atypical Orientals have an enzymatically inactive but immunologically crossreactive material (CRM) in their livers (5) . The amino acid composition, subunit molecular size, and immunological characteristics of CRM were indistinguishable from the corresponding properties of ALDH2 but differed from those of ALDH1 (6) . Therefore, CRM should be an abnormal defective protein resulting from a mutation of the ALDH2 locus. Genetic study indi- cates that two common alleles-i.e., ALDH12 for the usual ALDH2 isozyme and atypical ALDH22 for the defective CRM at the same locus-are codominantly expressed in Orientals (7) . The present paper reports the molecular difference between the usual ALDH2 and the enzymatically inactive CRM.
MATERIALS AND METHODS
ALDH and CRM. Two ALDH isozymes-i.e., ALDH1 and ALDH,-were purified from autopsy specimens of human liver as described (6) . CRM and ALDH1 were purified from atypical Japanese livers, which contained the ALDH1 isozyme but not the active ALDH2 isozyme, as described (6) . Purities of the samples were checked by polyacrylamide gel electrophoresis in the presence of NaDodSO4 as described (6) . The proteins were thoroughly dialyzed against water and lyophilized.
S-Carboxymethylation and Digestion by Trypsin. The lyophilized proteins (about 15 mg of each) were denatured, reduced, and S-carboxymethylated. The procedure was essentially the same as the one previously described (8) , except that guanidine hydrochloride (6 M), instead of urea, was used for denaturation, and [3H]iodoacetate, 0.3 mCi (1 Ci = 3.7 x 1010 Bq), was included in the reagents. The S-carboxymethylated protein was digested by trypsin (Sigma, type XI, diphenylcarbamylochloride treated). The protein/trypsin ratio was 30:1 (wt/wt), and the digestion was carried out at 25°C for 8 hr, maintaining the pH at 8.0 with ammonium carbonate. The digests were mixed with acetic acid to adjust the pH to 4.0 and lyophilized.
Peptide Mapping. The tryptic digests, about 4 mg of each, were used for peptide mapping on Whatman 3MM paper. The first dimension was descending chromatography using 1-butanol/acetic acid/H20, 4:1:5 (vol/vol) (upper phase), for 18 hr, and the second dimension was electrophoresis using acetic acid/pyridine/H20, 1:0.5:100 (vol/vol) (pH 5.1), at 30 V/cm for 90 min. The peptides were stained by 0.03% ninhydrin in acetone. The peptide spots that contained radioactive S-carboxymethylcysteine were located in the autoradiogram of the peptide maps.
Separation of Tryptic Peptides by HPLC. The tryptic digests, about 1 mg of each, were dissolved in 100 ,A of 0.1% trifluoroacetic acid and separated by reverse-phase HPLC using uBondapak C18 (10 ,um, 0.39 x 30 cm, Waters Associates). A Spectra Physics (Santa Clara, CA) pump system was used to produce a linear gradient from 0.1% trifluoroacetic acid in H20 to 0.07% trifluoroacetic acid in 50% H20 and 50% acetonitrile during a 60-min period at a flow rate of 1 ml/min. Peptides were monitored at 220 nm. Radioactivity of the peptide peaks was measured by a liquid scintillation 
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-? t: hydrolyzed in constant boiling hydrochloric acid for 24 hr at 110°C. Amino acids were determined by a Beckman model 6300 automatic amino acid analyzer. The amino acid sequences of the peptides were determined by manual Edman degradation identifying the products as dansyl amino acids and as phenylthiohydantoin derivatives (9) . Dansyl amino acids were identified by thin-layer chromatography, and phenylthiohydantoin derivatives were identified by back hydrolysis with 5.7 M HCl containing 0.1% SnCl2 (10). Phenylthiohydantoin-aspartic acid and phenylthiohydantoin-asparagine were distinguished by thin-layer chromatography (11). Val-Lys Peptide X and several adjacent peptides specified in Fig. 1 were eluted from the peptide maps and analyzed. Amino acids present as <3 nmol are not included. No correction was made for the partial decomposition of NH2-terminal residues by the ninhydrin reagent used for staining.
RESULTS AND DISCUSSION
Peptide maps of the tryptic digests of S-carboxymethylated ALDH2 and CRM were identical except that the spot marked X existing in CRM was absent in ALDH2 (Fig. 1) . All eight radioactive peptides-i.e., peptides that contained S-carboxymethylcysteine-were common in both proteins. Determination of the amino acid composition and sequence revealed that peptide X was Val-Lys (Table 1) .
The elution profiles of the two tryptic digests from the reverse-phase column indicated a clear difference between ALDH2 and CRM. The peak marked A in the ALDH2 profile was absent in the CRM profile, whereas the peak marked C in the CRM profile was absent in the ALDH2 profile (Fig. 2) . From the amino acid compositions (Table 2 ) and the results of Edman degradation of peptide A and peptide C (Fig. 3) , the structural difference between ALDH2 and CRM was deduced. Peptide C was two amino acids shorter than peptide A-i.e., missing -Gln-Val-proximal to the COOH-terminal lysine. Because the tryptic digests of CRM contained ValLys, which was absent in that of ALDH2, one can conclude that the glutamine residue next to valine of ALDH2 was substituted by lysine in CRM. The amino acid substitution found-i.e., glutamine -* lysine-is most probably the only abnormality'in CRM, although the possibility of the existence of an additional molecular abnormality that could not be detected by the present analysis is not ruled out. The substitution from glutamine to lysine is compatible with the fact that CRM moved slower towards the anode than ALDH2 in electrophoresis (5) . CRM has no ALDH activity and diminished or no affinity for NAD (6) . Therefore, the glutamine residue at this specific position must play a crucial role for exhibiting ALDH activiProc. Natl. Acad ScL USA 81 (1984) Proc. NatL. Acad. Sci Glu-Ieu-Gly-Glu-Ala-Gly-Leu-Gln-Ala-Asn-Val-ysiVal-Lys
Structural difference between ALDH2 and CRM. The amino acid sequence of peptide A obtained from ALDH2 and that of peptide C obtained from CRM were determined by manual Edman degradation. The structure of peptide X obtained from CRM was deduced from its amino acid composition. Arrow ( ) shows the trypsin-sensitive bond of the CRM peptide. The positions of the structural difference are underlined.
ty, and the replacement of this glutamine by lysine induces total loss in enzyme activity. It remains unknown whether the glutamine directly participates to form an NAD binding site or whether it plays a role in maintenance of an appropriate three-dimensional structure of the enzyme so that replacement of the glutamine residue by lysine induces conformational changes.
From horse mitochondrial ALDH (corresponding to human ALDH2), Bahr-Lindstrom et al. isolated a tryptic peptide containing cysteine, which was implicated in the coenzyme binding site of the enzyme (12) . The present human tryptic peptide with the amino acid substitution has no homology with the horse peptide they obtained, indicating that these peptides are located in different parts of the enzyme molecules. All eight tryptic peptides containing cysteine were common in ALDH2 and CRM ( Figs. 1 and 2 ), indicating that no structural abnormality exists in the vicinity of the active site cysteine of CRM.
Peptide X, Val-Lys, could not be detected by the HPLC analysis (Fig. 2) . On the other hand, the peptide substitution-i.e., peptide C in CRM for peptide A in ALDH2-was clearly detected by HPLC analysis but was not observed in the peptide maps. Peptide X was presumably superimposed upon other small peptides in the HPLC profiles, and peptide A and peptide C, which were expected to have very similar charges and hydrophobicities, could not be separated by the two-dimensional paper chromatography and electrophoresis. Two methods-i.e., separation of the peptides by HPLC and peptide mapping on paper-were needed for elucidating the molecular abnormality of the inactive CRM.
All animals thus far reported have two major ALDH isozymes in their livers (13, 14) . ALDH1 is cytosolic in origin, has a low Km for NAD and a high Km for acetaldehyde, and is inactivated by disulfiraih; ALDH2 is mitochondrial in origin, has a high Km for NAD and a low Km for acetaldehyde, and is resistant to disulfiram (15, 16) . The two isozymes exhibit certain serological homology, indicating that they probably differentiated from a common ancester (6, 17 (3, 4) . The frequency of the mutant ALDH22 gene is estimated to be about 70% and that of the usual ALDH12 gene is estimated to be about 30% in Japanese and Chinese. By contrast, the frequency of the mutant gene is found to be very rare in Caucasians and several other ethnic populations (3). The atypical subjects without active ALDH2 enzyme are physiologically normal, except for a possible association with acute alcohol sensitivity (3). Therefore, the mitochondrial ALDH2 appears to be unessential in' man, although it might have been essential at certain stages of evolution, and it may still have some physiological role in other animal species. Recently, we found a subject who has ALDH2 isozyme but not ALDH1 isozyme (7) . The subject exhibited no physiological abnormality. The cytosolic ALDH1 and the mitochondrial ALDH2 are probably complements to each other, and the presence of either one of these two isozymes may thus fulfill the physiological requirement, at least in man.
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